Free Republic

UK trials new antibody therapy that can stop people who have been exposed to COVID becoming ill and it could save MILLIONS of lives across the globe Drug would offer immediate and long-term protection to patients when it would be too late to offer a vaccine It could be given as an emergency treatment to hospital inpatients, care home residents and university students to help reduce the spread of the virus Scientists from the University College London Hospitals NHS (UCLH) have injected ten people with the drug In the U.S. there have been more than 18.7 million Americans infected with...

The study recruited the first participant in the world to the study earlier this month and has recruited 10 participants since then Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19. The University College London Hospitals NHS Trust (UCLH) said that the researchers in the Storm Chase study believe a Long Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to the SARS-CoV-2 coronavirus and prevent them developing COVID-19. The study, led by UCLH virologist...

Tiny biotech company Sorrento Therapeutics (SRNE) claimed Friday its experimental coronavirus treatment is a cure for Covid-19. Meanwhile, another company said it gained authorization for a coronavirus test. In preclinical testing, Sorrento's antibody drug provided "100% inhibition" of SARS-CoV-2 — the new coronavirus that causes Covid-19 — within four days. Sorrento expects this antibody to be the first in a drug cocktail that would create a "protective shield" against infection. "Our STI-1499 antibody shows exceptional therapeutic potential and could potentially save lives following receipt of necessary approvals," Chief Executive Henry Ji said in a written statement. "We at Sorrento are...